These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18006080)

  • 21. Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis.
    Osmers I; Smith SS; Parks BW; Yu S; Srivastava R; Wohler JE; Barnum SR; Kabarowski JH
    J Neuroimmunol; 2009 Feb; 207(1-2):18-23. PubMed ID: 19135725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanism of immune tolerance induced by soluble myelin oligodendrocyte glycoprotein in mice with experimental autoimmune encephalomyelitis].
    Zheng P; Ma P; Fu H; Dong R; Yang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 May; 34(5):414-420. PubMed ID: 30043732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.
    Peng Y; Zhu FZ; Chen ZX; Zhou JX; Gan L; Yang SS; Gao S; Liu QQ
    Chin Med J (Engl); 2019 Dec; 132(24):2934-2940. PubMed ID: 31855963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
    Carambia A; Freund B; Schwinge D; Bruns OT; Salmen SC; Ittrich H; Reimer R; Heine M; Huber S; Waurisch C; Eychmüller A; Wraith DC; Korn T; Nielsen P; Weller H; Schramm C; Lüth S; Lohse AW; Heeren J; Herkel J
    J Hepatol; 2015 Jun; 62(6):1349-56. PubMed ID: 25617499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.
    Zappia E; Casazza S; Pedemonte E; Benvenuto F; Bonanni I; Gerdoni E; Giunti D; Ceravolo A; Cazzanti F; Frassoni F; Mancardi G; Uccelli A
    Blood; 2005 Sep; 106(5):1755-61. PubMed ID: 15905186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
    Kozela E; Juknat A; Gao F; Kaushansky N; Coppola G; Vogel Z
    J Neuroinflammation; 2016 Jun; 13(1):136. PubMed ID: 27256343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
    Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
    Komiyama Y; Nakae S; Matsuki T; Nambu A; Ishigame H; Kakuta S; Sudo K; Iwakura Y
    J Immunol; 2006 Jul; 177(1):566-73. PubMed ID: 16785554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
    Carrier Y; Yuan J; Kuchroo VK; Weiner HL
    J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
    J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
    Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y
    J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease.
    Mendel I; Shoham A; Propheta-Meiran O; Ishai E; Halperin G; Feige E; Breitbart E
    J Neuroimmunol; 2010 Sep; 226(1-2):126-35. PubMed ID: 20663571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
    Steckner C; Weber A; Mausberg AK; Heininger M; Opdenhövel F; Kieseier BC; Hartung HP; Hofstetter HH
    Clin Immunol; 2016 Sep; 170():22-30. PubMed ID: 27233983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development.
    Hasegawa H; Mizoguchi I; Orii N; Inoue S; Katahira Y; Yoneto T; Xu M; Miyazaki T; Yoshimoto T
    Sci Rep; 2021 Mar; 11(1):5266. PubMed ID: 33664371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
    Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
    Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of ICAM-1 and P-selectin expression in the development and effector function of CD4+CD25+regulatory T cells.
    Kohm AP; Miller SD
    J Autoimmun; 2003 Nov; 21(3):261-71. PubMed ID: 14599851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
    J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depletion of CD4(+)CD25(+) T cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens.
    Akirav EM; Bergman CM; Hill M; Ruddle NH
    J Neurosci Res; 2009 Nov; 87(15):3511-9. PubMed ID: 19125411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
    Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
    J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.